Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes

Omar D. Hudson, Martha Nunez, Gabriel Shaibi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: To examine the influence of ethnicity on liver transaminases among adolescents with type 2 diabetes mellitus (T2DM).Methods: A retrospective medical chart review of 57 (30 males and 27 females) newly diagnosed patients with T2DM. Ethnicity was determined by self-report and height, weight, body mass index (BMI) and glycosylated hemoglobin (HbA1c) were obtained using standard clinical procedures. Fasting levels of alanine aminotransaminase (ALT) and aspartate aminotransferase (AST) were collected prior to the initiation of any therapy.Results: Age, gender, height, weight, BMI, and HbA1c did not differ between ethnic groups. Compared to African-Americans, Hispanics had significantly higher ALT (23.9 ± 3.4 vs. 107.8 ± 20.3, p=0.002) and AST (17.7 ± 2.5 vs. 71.1 ± 15.7, p<0.001) and were significantly more likely to have ALT values above the upper limit of normal (20% vs. 71%, p=0.005) and twice the upper limit of normal (0% vs. 39%, p=0.05) as well as AST values above the upper limit of normal (0% vs. 53%, p=0.002). No differences in ALT or AST were found between Hispanics and non-Hispanic whites or between African-Americans and non-Hispanic whites.Conclusions: These preliminary findings suggest that Hispanic children with T2DM may be at higher risk for developing non-alcoholic fatty liver disease and indicate that a comprehensive hepatic evaluation is warranted in this population. Future studies that incorporate more precise and proximal measures of liver health are warranted in this population.

Original languageEnglish (US)
Article number174
JournalBMC Pediatrics
Volume12
DOIs
StatePublished - Nov 7 2012

Fingerprint

Aspartate Aminotransferases
Transaminases
Type 2 Diabetes Mellitus
Hispanic Americans
Liver
Alanine Transaminase
Alanine
African Americans
Body Mass Index
Weights and Measures
Glycosylated Hemoglobin A
Ethnic Groups
Self Report
Population
Fasting
Health
Therapeutics

Keywords

  • Alanine aminotransferase
  • Aspartate aminotransferase
  • Fatty liver
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. / Hudson, Omar D.; Nunez, Martha; Shaibi, Gabriel.

In: BMC Pediatrics, Vol. 12, 174, 07.11.2012.

Research output: Contribution to journalArticle

@article{51ed98a6dfac4bc4973e8de7d013f64c,
title = "Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes",
abstract = "Background: To examine the influence of ethnicity on liver transaminases among adolescents with type 2 diabetes mellitus (T2DM).Methods: A retrospective medical chart review of 57 (30 males and 27 females) newly diagnosed patients with T2DM. Ethnicity was determined by self-report and height, weight, body mass index (BMI) and glycosylated hemoglobin (HbA1c) were obtained using standard clinical procedures. Fasting levels of alanine aminotransaminase (ALT) and aspartate aminotransferase (AST) were collected prior to the initiation of any therapy.Results: Age, gender, height, weight, BMI, and HbA1c did not differ between ethnic groups. Compared to African-Americans, Hispanics had significantly higher ALT (23.9 ± 3.4 vs. 107.8 ± 20.3, p=0.002) and AST (17.7 ± 2.5 vs. 71.1 ± 15.7, p<0.001) and were significantly more likely to have ALT values above the upper limit of normal (20{\%} vs. 71{\%}, p=0.005) and twice the upper limit of normal (0{\%} vs. 39{\%}, p=0.05) as well as AST values above the upper limit of normal (0{\%} vs. 53{\%}, p=0.002). No differences in ALT or AST were found between Hispanics and non-Hispanic whites or between African-Americans and non-Hispanic whites.Conclusions: These preliminary findings suggest that Hispanic children with T2DM may be at higher risk for developing non-alcoholic fatty liver disease and indicate that a comprehensive hepatic evaluation is warranted in this population. Future studies that incorporate more precise and proximal measures of liver health are warranted in this population.",
keywords = "Alanine aminotransferase, Aspartate aminotransferase, Fatty liver, Type 2 diabetes mellitus",
author = "Hudson, {Omar D.} and Martha Nunez and Gabriel Shaibi",
year = "2012",
month = "11",
day = "7",
doi = "10.1186/1471-2431-12-174",
language = "English (US)",
volume = "12",
journal = "BMC Pediatrics",
issn = "1471-2431",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes

AU - Hudson, Omar D.

AU - Nunez, Martha

AU - Shaibi, Gabriel

PY - 2012/11/7

Y1 - 2012/11/7

N2 - Background: To examine the influence of ethnicity on liver transaminases among adolescents with type 2 diabetes mellitus (T2DM).Methods: A retrospective medical chart review of 57 (30 males and 27 females) newly diagnosed patients with T2DM. Ethnicity was determined by self-report and height, weight, body mass index (BMI) and glycosylated hemoglobin (HbA1c) were obtained using standard clinical procedures. Fasting levels of alanine aminotransaminase (ALT) and aspartate aminotransferase (AST) were collected prior to the initiation of any therapy.Results: Age, gender, height, weight, BMI, and HbA1c did not differ between ethnic groups. Compared to African-Americans, Hispanics had significantly higher ALT (23.9 ± 3.4 vs. 107.8 ± 20.3, p=0.002) and AST (17.7 ± 2.5 vs. 71.1 ± 15.7, p<0.001) and were significantly more likely to have ALT values above the upper limit of normal (20% vs. 71%, p=0.005) and twice the upper limit of normal (0% vs. 39%, p=0.05) as well as AST values above the upper limit of normal (0% vs. 53%, p=0.002). No differences in ALT or AST were found between Hispanics and non-Hispanic whites or between African-Americans and non-Hispanic whites.Conclusions: These preliminary findings suggest that Hispanic children with T2DM may be at higher risk for developing non-alcoholic fatty liver disease and indicate that a comprehensive hepatic evaluation is warranted in this population. Future studies that incorporate more precise and proximal measures of liver health are warranted in this population.

AB - Background: To examine the influence of ethnicity on liver transaminases among adolescents with type 2 diabetes mellitus (T2DM).Methods: A retrospective medical chart review of 57 (30 males and 27 females) newly diagnosed patients with T2DM. Ethnicity was determined by self-report and height, weight, body mass index (BMI) and glycosylated hemoglobin (HbA1c) were obtained using standard clinical procedures. Fasting levels of alanine aminotransaminase (ALT) and aspartate aminotransferase (AST) were collected prior to the initiation of any therapy.Results: Age, gender, height, weight, BMI, and HbA1c did not differ between ethnic groups. Compared to African-Americans, Hispanics had significantly higher ALT (23.9 ± 3.4 vs. 107.8 ± 20.3, p=0.002) and AST (17.7 ± 2.5 vs. 71.1 ± 15.7, p<0.001) and were significantly more likely to have ALT values above the upper limit of normal (20% vs. 71%, p=0.005) and twice the upper limit of normal (0% vs. 39%, p=0.05) as well as AST values above the upper limit of normal (0% vs. 53%, p=0.002). No differences in ALT or AST were found between Hispanics and non-Hispanic whites or between African-Americans and non-Hispanic whites.Conclusions: These preliminary findings suggest that Hispanic children with T2DM may be at higher risk for developing non-alcoholic fatty liver disease and indicate that a comprehensive hepatic evaluation is warranted in this population. Future studies that incorporate more precise and proximal measures of liver health are warranted in this population.

KW - Alanine aminotransferase

KW - Aspartate aminotransferase

KW - Fatty liver

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=84868314304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868314304&partnerID=8YFLogxK

U2 - 10.1186/1471-2431-12-174

DO - 10.1186/1471-2431-12-174

M3 - Article

C2 - 23134937

AN - SCOPUS:84868314304

VL - 12

JO - BMC Pediatrics

JF - BMC Pediatrics

SN - 1471-2431

M1 - 174

ER -